QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

23,174 signal articles · 357 in last 24h · 110,767 total before filter · latest 50m ago
357last 24h
2376last 7d
428● bullish (7d)
221● bearish (7d)
202publishers
AllMacro259Earnings1445M&A99Regulatory17Product17Analyst22
✕ clear all filtersticker: EDSASentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment
Insider Monkey113d agoneutral
Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment

Edesa Biotech Inc. (NASDAQ:EDSA) is one of the 10 Unstoppable Stocks That Could Double Your Money. Edesa Biotech Inc. (NASDAQ:EDSA) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical study of EB06, which is a treatment for moderate-to-severe nonsegmental vitiligo, is […]